The global in-vitro fertilization (IVF) market size is expected to reach USD 36.39 billion by 2026, exhibiting a CAGR of 10.1% during the forecast period. The increasing cases of infertility can be a critical factor bolstering the growth of the market during the forecast period, states Fortune Business Insights™ in a report titled “In Vitro Fertilization (IVF) Market Size, Share & Industry Analysis, By Type (Conventional IVF, and IVF with ICSI), By Procedure (Fresh Non-donor, Frozen Non-donor, Fresh Donor, and Frozen Donor), By End User (Hospitals, and Fertility Clinics) and Regional Forecast, 2019-2026” the market size stood at USD 16.89 billion in 2018.
The Report Lists the Leading Companies in the IVF Market:
- Boston IVF
- Monash IVF
- Pelargos IVF
- Ovation Fertility
- RSMC
- Shady Grove Fertility
- Group Ambroise Paré Clinic
- Bangkok IVF center
- Bloom IVF Centre
- Other Service Providers
 |
| Get Sample PDF Brochure |
The IVF Market Research Report Contains:
- Through analysis of all the sections in the market
- Informative data and figures
- Market trends and drivers
- Superior insights into all emerging developments
DRIVING FACTORS-
Increasing Demand for ICSI treatment to Augment Growth
The growing
awareness about infertility will spur demand for the treatment of IVF in the
forthcoming years. The growing introduction of advanced treatment of
intracytoplasmic sperm injection (ICSI) will drive the market in the
foreseeable future. The rising medicinal and surgical procedures for IVF
treatment will enable speedy expansion of the market. IVF is the process of
fertilization by extracting eggs, retrieving a sperm sample, and then manually
combining egg and sperm in a laboratory. The rising adoption of the IVF
technique among infertile couples will subsequently create lucrative
opportunities for the market during the forecast period. The rising emphasis on
assisted reproductive techniques will boost the demand of the market. The
increasing popularity of IVF & ICSI treatment is likely to foster the
growth of the in vitro fertilization (IVF) market.
Get a Detailed Summary of This Report:
https://www.fortunebusinessinsights.com/in-vitro-fertilization-ivf-market-102189
RESTRAINING FACTORS-
High Risks of IVF Treatment to Limit Market Growth
The high
risks associated with IVF and ICSI treatment will subsequently limit the growth
of the market during the forecast period. For instance, according to a data
published by the Reproductive Science Center, a rare condition called
“Imprinting Disorders” associated with IVF procedures estimated that the risk
of such disorders with IVF treatment was around 2 to 5 per 15,000 births using
IVF technique, while the risk in general cases was 1 in 15,000 normal births.
Thus, the potential risks and birth defects associated with IVF treatment and
high-priced treatment of IVF are factors expected to dampen the growth of the
market during the forecast period.
REGIONAL INSIGHTS-
Rising Prevalence of Infertility to Aid Expansion in Europe
The market
in Europe generated a revenue of USD
7.57 billion in 2018. The growth in the region is attributed to the
increasing prevalence of infertility. The growing success rate of IVF treatment
countries such as Spain and Denmark will further aid the development of the
market in Europe. According to data published by the European Society of Human
Reproduction and Embryology (ESHRE) states that the pregnancy rate per
treatment in Europe in 2016 was around 30.5% which witnessed a growth of 1.3%
than the previous year owing to the high success rate of IVF & ICSI
procedures.
The market
in Asia Pacific is expected to grow rapidly during the forecast period owing to
the surge in medical tourism. The rising awareness regarding infertility will
have a tremendous impact on the market in the region. The higher adoption of
IVF treatment will consequently foster the growth of the market in the
forthcoming years. For instance, according to the Fertility Society of
Australia, in 2018 there were around 120 registered clinics present in
Australia, among which almost 98.0% were providing IVF services.
INDUSTRY DEVELOPMENTS-
- May 2019: NMC Health plc, announced that
it has acquired a majority of stake in Boston IVF to create the most
diversified and experienced fertility network in the world.
- May 2019: Scientists of Monash unveiled a
new embryo screening test to reduce the risk of miscarriage during IVF
treatment.
No comments:
Post a Comment